Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.06
MMSI's Cash-to-Debt is ranked lower than
97% of the 170 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.62 vs. MMSI: 0.06 )
Ranked among companies with meaningful Cash-to-Debt only.
MMSI' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.02  Med: 0.08 Max: No Debt
Current: 0.06
Equity-to-Asset 0.53
MMSI's Equity-to-Asset is ranked lower than
59% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. MMSI: 0.53 )
Ranked among companies with meaningful Equity-to-Asset only.
MMSI' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.45  Med: 0.68 Max: 0.84
Current: 0.53
0.45
0.84
Interest Coverage 3.96
MMSI's Interest Coverage is ranked lower than
87% of the 139 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 39.93 vs. MMSI: 3.96 )
Ranked among companies with meaningful Interest Coverage only.
MMSI' s Interest Coverage Range Over the Past 10 Years
Min: 3.46  Med: 35.47 Max: 7656.67
Current: 3.96
3.46
7656.67
Piotroski F-Score: 6
Altman Z-Score: 3.13
Beneish M-Score: -2.54
WACC vs ROIC
8.65%
-75.99%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 5.78
MMSI's Operating Margin % is ranked higher than
54% of the 169 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.65 vs. MMSI: 5.78 )
Ranked among companies with meaningful Operating Margin % only.
MMSI' s Operating Margin % Range Over the Past 10 Years
Min: 5.78  Med: 7.7 Max: 13.64
Current: 5.78
5.78
13.64
Net Margin % 3.33
MMSI's Net Margin % is ranked higher than
51% of the 169 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.14 vs. MMSI: 3.33 )
Ranked among companies with meaningful Net Margin % only.
MMSI' s Net Margin % Range Over the Past 10 Years
Min: 3.33  Med: 4.76 Max: 9.13
Current: 3.33
3.33
9.13
ROE % 4.19
MMSI's ROE % is ranked higher than
51% of the 162 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.92 vs. MMSI: 4.19 )
Ranked among companies with meaningful ROE % only.
MMSI' s ROE % Range Over the Past 10 Years
Min: 4.17  Med: 5.47 Max: 11.56
Current: 4.19
4.17
11.56
ROA % 2.36
MMSI's ROA % is ranked higher than
54% of the 171 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.93 vs. MMSI: 2.36 )
Ranked among companies with meaningful ROA % only.
MMSI' s ROA % Range Over the Past 10 Years
Min: 2.31  Med: 3.66 Max: 9.59
Current: 2.36
2.31
9.59
ROC (Joel Greenblatt) % 8.36
MMSI's ROC (Joel Greenblatt) % is ranked lower than
52% of the 169 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.86 vs. MMSI: 8.36 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
MMSI' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 8.32  Med: 10.66 Max: 21.49
Current: 8.36
8.32
21.49
3-Year Revenue Growth Rate 8.70
MMSI's 3-Year Revenue Growth Rate is ranked higher than
68% of the 147 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.10 vs. MMSI: 8.70 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
MMSI' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0.9  Med: 9.8 Max: 18.6
Current: 8.7
0.9
18.6
3-Year EBITDA Growth Rate 7.20
MMSI's 3-Year EBITDA Growth Rate is ranked higher than
52% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.10 vs. MMSI: 7.20 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
MMSI' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -9.1  Med: 9.7 Max: 50.4
Current: 7.2
-9.1
50.4
3-Year EPS without NRI Growth Rate 4.90
MMSI's 3-Year EPS without NRI Growth Rate is ranked lower than
51% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.50 vs. MMSI: 4.90 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
MMSI' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -16.5  Med: 4.8 Max: 160.4
Current: 4.9
-16.5
160.4
GuruFocus has detected 7 Warning Signs with Merit Medical Systems Inc $MMSI.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» MMSI's 10-Y Financials

Financials (Next Earnings Date: 2017-05-21 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

MMSI Guru Trades in Q1 2016

Ken Fisher 185,797 sh (+8.66%)
Paul Tudor Jones Sold Out
Jim Simons 486,900 sh (-7.77%)
Chuck Royce 627,786 sh (-22.11%)
» More
Q2 2016

MMSI Guru Trades in Q2 2016

Paul Tudor Jones 12,139 sh (New)
Ken Fisher 185,797 sh (unchged)
Chuck Royce 627,786 sh (unchged)
Jim Simons 362,200 sh (-25.61%)
» More
Q3 2016

MMSI Guru Trades in Q3 2016

Steven Cohen 224,600 sh (New)
Chuck Royce 627,786 sh (unchged)
Paul Tudor Jones 11,714 sh (-3.50%)
Ken Fisher 145,380 sh (-21.75%)
Jim Simons 276,900 sh (-23.55%)
» More
Q4 2016

MMSI Guru Trades in Q4 2016

Steven Cohen 289,400 sh (+28.85%)
Jim Simons 301,400 sh (+8.85%)
Chuck Royce 627,786 sh (unchged)
Paul Tudor Jones Sold Out
Ken Fisher 80,121 sh (-44.89%)
» More
» Details

Insider Trades

Latest Guru Trades with MMSI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339112    SIC: 3841
Compare:NAS:BIOL, NAS:BLFS, NAS:BMRA, NYSE:BAX, NYSE:BDX » details
Traded in other countries:MM3.Germany,
Merit Medical Systems Inc designs, develops, manufactures and sells medical devices used in interventional and diagnostic procedures. Its products are used in thoracic surgery, interventional nephrology, vascular surgery, and oncology and pain management.

Merit Medical Systems Inc was organized in July 1987 as a Utah corporation. The Company designs, develops, manufactures and sells medical devices used in interventional and diagnostic procedures. It provides its products to physicians and healthcare professionals to enhance patient care and enable them to perform procedures safely and effectively. Its operations are divided into the following principal markets: diagnostic and interventional cardiology, interventional radiology, interventional gastroenterology, interventional pulmonology, vascular surgery, interventional nephrology, and thoracic surgery. Its devices include Rad Board, Rad Board Xtra, Rad Trac and Rad Rest, which are used for patient positioning during radial access procedures; Safeguard Pressure Assisted Device, which assists in obtaining and maintaining hemostasis after a femoral procedure, and the Air-Band Radial Compression Device, which is indicated to assist hemostasis of the radial artery puncture site while maintaining visibility. The Company's products are also used in other clinical areas such as thoracic surgery, interventional nephrology, vascular surgery, and oncology and pain management. The Company offers safety-related products and kits. Its ShortStop and ShortStop Advantage Temporary Sharps Holders address the potential safety issues associated with accidental needle sticks. Its extensive line of color-coded Medallion Syringes and the PAL Pen and Label Medication Labeling System comply with patient safety initiatives of The Joint Commission and are designed to help minimize mix-ups in administering medication. It also offers waste management products to help avoid accidental exposure to contaminated fluids such as Occupational Safety and Health Administration compliant waste disposal basins: the BackStop, BackStop+, MiniStop, MiniStop+, and DugOut. The Company offer devices used to gain and maintain vascular access while protecting the clinician from accidental cuts and needle sticks during procedures such as the Futura Safety Scalpel and angiography needles such as the Merit Advance and the SecureLoc Safety Introducer Needle. It also offers sheath introducers such as Prelude and mini access kits such as MAK and S-MAK, designed to provide clinicians with smooth, less traumatic, and convenient access to the patient's vasculature. The Company offers the Clo-Sur PLUS P.A.D, intended for the local management of bleeding wounds and the creation of a barrier to bacterial penetration. It also offers two independent, differentiated radial compression systems, the Finale Compression Device and the RADStat Radial Artery Compression Device. Its diagnostic guide wires are used to traverse vascular anatomy and aid in placing catheters and other devices such as the pre-coated InQwire Diagnostic Guide Wires. The Merit Laureate Hydrophilic Guide Wire promotes rapid catheter exchanges and minimizes friction. It also offers the BowTie Guide Wire Insertion Device, us

Ratios

vs
industry
vs
history
PE Ratio 63.84
MMSI's PE Ratio is ranked lower than
86% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.58 vs. MMSI: 63.84 )
Ranked among companies with meaningful PE Ratio only.
MMSI' s PE Ratio Range Over the Past 10 Years
Min: 12.91  Med: 29.16 Max: 69.67
Current: 63.84
12.91
69.67
Forward PE Ratio 24.75
MMSI's Forward PE Ratio is ranked lower than
53% of the 40 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.77 vs. MMSI: 24.75 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 63.84
MMSI's PE Ratio without NRI is ranked lower than
85% of the 130 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.48 vs. MMSI: 63.84 )
Ranked among companies with meaningful PE Ratio without NRI only.
MMSI' s PE Ratio without NRI Range Over the Past 10 Years
Min: 13.03  Med: 29.22 Max: 69.67
Current: 63.84
13.03
69.67
Price-to-Owner-Earnings 163.24
MMSI's Price-to-Owner-Earnings is ranked lower than
94% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.68 vs. MMSI: 163.24 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
MMSI' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 22.45  Med: 61.18 Max: 2796
Current: 163.24
22.45
2796
PB Ratio 2.57
MMSI's PB Ratio is ranked higher than
57% of the 172 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.39 vs. MMSI: 2.57 )
Ranked among companies with meaningful PB Ratio only.
MMSI' s PB Ratio Range Over the Past 10 Years
Min: 1.08  Med: 1.98 Max: 3.2
Current: 2.57
1.08
3.2
PS Ratio 2.13
MMSI's PS Ratio is ranked higher than
57% of the 173 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. MMSI: 2.13 )
Ranked among companies with meaningful PS Ratio only.
MMSI' s PS Ratio Range Over the Past 10 Years
Min: 1.03  Med: 1.62 Max: 2.69
Current: 2.13
1.03
2.69
Price-to-Free-Cash-Flow 69.56
MMSI's Price-to-Free-Cash-Flow is ranked lower than
82% of the 74 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.63 vs. MMSI: 69.56 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
MMSI' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 21.84  Med: 46.04 Max: 188.41
Current: 69.56
21.84
188.41
Price-to-Operating-Cash-Flow 24.00
MMSI's Price-to-Operating-Cash-Flow is ranked lower than
69% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.91 vs. MMSI: 24.00 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
MMSI' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 9.2  Med: 14.6 Max: 29.17
Current: 24
9.2
29.17
EV-to-EBIT 46.48
MMSI's EV-to-EBIT is ranked lower than
86% of the 104 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.63 vs. MMSI: 46.48 )
Ranked among companies with meaningful EV-to-EBIT only.
MMSI' s EV-to-EBIT Range Over the Past 10 Years
Min: 8.1  Med: 22.1 Max: 50.1
Current: 46.48
8.1
50.1
EV-to-EBITDA 20.38
MMSI's EV-to-EBITDA is ranked lower than
70% of the 115 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.65 vs. MMSI: 20.38 )
Ranked among companies with meaningful EV-to-EBITDA only.
MMSI' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.1  Med: 12.95 Max: 22
Current: 20.38
6.1
22
PEG Ratio 8.29
MMSI's PEG Ratio is ranked lower than
89% of the 55 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.82 vs. MMSI: 8.29 )
Ranked among companies with meaningful PEG Ratio only.
MMSI' s PEG Ratio Range Over the Past 10 Years
Min: 1.05  Med: 4.47 Max: 96.23
Current: 8.29
1.05
96.23
Shiller PE Ratio 53.16
MMSI's Shiller PE Ratio is ranked lower than
67% of the 46 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 44.61 vs. MMSI: 53.16 )
Ranked among companies with meaningful Shiller PE Ratio only.
MMSI' s Shiller PE Ratio Range Over the Past 10 Years
Min: 18.07  Med: 29.84 Max: 58.06
Current: 53.16
18.07
58.06
Current Ratio 2.76
MMSI's Current Ratio is ranked higher than
57% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.37 vs. MMSI: 2.76 )
Ranked among companies with meaningful Current Ratio only.
MMSI' s Current Ratio Range Over the Past 10 Years
Min: 2.03  Med: 3.08 Max: 5.08
Current: 2.76
2.03
5.08
Quick Ratio 1.39
MMSI's Quick Ratio is ranked lower than
63% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.62 vs. MMSI: 1.39 )
Ranked among companies with meaningful Quick Ratio only.
MMSI' s Quick Ratio Range Over the Past 10 Years
Min: 0.87  Med: 1.51 Max: 3.56
Current: 1.39
0.87
3.56
Days Inventory 121.56
MMSI's Days Inventory is ranked higher than
54% of the 156 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 126.59 vs. MMSI: 121.56 )
Ranked among companies with meaningful Days Inventory only.
MMSI' s Days Inventory Range Over the Past 10 Years
Min: 98.79  Med: 117.35 Max: 132.82
Current: 121.56
98.79
132.82
Days Sales Outstanding 48.67
MMSI's Days Sales Outstanding is ranked higher than
76% of the 140 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 62.14 vs. MMSI: 48.67 )
Ranked among companies with meaningful Days Sales Outstanding only.
MMSI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 41.18  Med: 47.04 Max: 52.07
Current: 48.67
41.18
52.07
Days Payable 32.99
MMSI's Days Payable is ranked lower than
77% of the 129 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 51.97 vs. MMSI: 32.99 )
Ranked among companies with meaningful Days Payable only.
MMSI' s Days Payable Range Over the Past 10 Years
Min: 28.96  Med: 38.12 Max: 59.55
Current: 32.99
28.96
59.55

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -1.30
MMSI's 3-Year Average Share Buyback Ratio is ranked higher than
63% of the 117 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.70 vs. MMSI: -1.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MMSI' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -6.5  Med: -2.1 Max: -0.6
Current: -1.3
-6.5
-0.6

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 12.37
MMSI's Price-to-Tangible-Book is ranked lower than
86% of the 144 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.55 vs. MMSI: 12.37 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
MMSI' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.61  Med: 3.58 Max: 12.37
Current: 12.37
1.61
12.37
Price-to-Intrinsic-Value-Projected-FCF 3.30
MMSI's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
75% of the 84 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.00 vs. MMSI: 3.30 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
MMSI' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.56  Med: 2.42 Max: 5.42
Current: 3.3
1.56
5.42
Price-to-Intrinsic-Value-DCF (Earnings Based) 5.96
MMSI's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
100% of the 21 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.07 vs. MMSI: 5.96 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.31
MMSI's Price-to-Median-PS-Value is ranked lower than
71% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. MMSI: 1.31 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
MMSI' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.3  Med: 1.05 Max: 2.72
Current: 1.31
0.3
2.72
Price-to-Peter-Lynch-Fair-Value 6.65
MMSI's Price-to-Peter-Lynch-Fair-Value is ranked lower than
93% of the 42 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.18 vs. MMSI: 6.65 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
MMSI' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.83  Med: 2.63 Max: 13.5
Current: 6.65
0.83
13.5
Price-to-Graham-Number 5.92
MMSI's Price-to-Graham-Number is ranked lower than
87% of the 82 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.60 vs. MMSI: 5.92 )
Ranked among companies with meaningful Price-to-Graham-Number only.
MMSI' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.28  Med: 2.23 Max: 5.92
Current: 5.92
1.28
5.92
Earnings Yield (Greenblatt) % 2.15
MMSI's Earnings Yield (Greenblatt) % is ranked higher than
50% of the 176 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.00 vs. MMSI: 2.15 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
MMSI' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 2  Med: 4.5 Max: 12.4
Current: 2.15
2
12.4
Forward Rate of Return (Yacktman) % 9.64
MMSI's Forward Rate of Return (Yacktman) % is ranked higher than
52% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.62 vs. MMSI: 9.64 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
MMSI' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -2.5  Med: 7.5 Max: 21.7
Current: 9.64
-2.5
21.7

More Statistics

Revenue (TTM) (Mil) $603.8
EPS (TTM) $ 0.45
Beta1.00
Short Percentage of Float4.13%
52-Week Range $17.14 - 31.70
Shares Outstanding (Mil)44.68

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 715 772 844
EPS ($) 1.16 1.31 1.42
EPS without NRI ($) 1.16 1.31 1.42
EPS Growth Rate
(Future 3Y To 5Y Estimate)
10.00%
Dividends per Share ($)
» More Articles for MMSI

Headlines

Articles On GuruFocus.com
Merit Medical Systems Inc. (MMSI) CFO Kent W Stanger sells 15,870 Shares Feb 11 2011 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Dec 16 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Nov 17 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Oct 18 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Sep 16 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Aug 18 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Jul 19 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares Jun 17 2010 
Merit Medical Systems Inc. (MMSI) President & CEO Fred P Lampropoulos sells 5,000 Shares May 21 2010 
Merit Medical Systems Inc. (MMSI) COO Arlin D Nelson sells 8,335 Shares Sep 25 2009 

More From Other Websites
3:32 am Merit Medical prices offering of 4.5 mln shares of common stock at $28.25 per share Mar 24 2017
Merit Medical (MMSI) Prices 4.5M Follow-On Share Offering Mar 23 2017
Merit Medical Announces Pricing of Public Offering of Common Stock Mar 22 2017
Merit Medical (MMSI) to Refinance Debt via Share Offering Mar 21 2017
MERIT MEDICAL SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation... Mar 20 2017
Merit Medical Announces Commencement of Public Offering of Common Stock Mar 20 2017
SA medical technology company lands major European deal Mar 08 2017
MERIT MEDICAL SYSTEMS INC Financials Mar 07 2017
MERIT MEDICAL SYSTEMS INC Files SEC form 10-K, Annual Report Mar 01 2017
[$$] Home Depot Looks Fit, UPS Looks Squeezed Feb 25 2017
MERIT MEDICAL SYSTEMS INC Files SEC form 8-K/A, Financial Statements and Exhibits Feb 24 2017
Merit Medical Systems, Inc. :MMSI-US: Earnings Analysis: 2016 By the Numbers : February 23, 2017 Feb 23 2017
Merit Medical Systems, Inc. :MMSI-US: Earnings Analysis: Q4, 2016 By the Numbers : February 23, 2017 Feb 23 2017
Edited Transcript of MMSI earnings conference call or presentation 21-Feb-17 10:00pm GMT Feb 22 2017
MERIT MEDICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 21 2017
Merit Medical beats 4Q profit forecasts Feb 21 2017
Merit Medical beats 4Q profit forecasts Feb 21 2017
Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2016 Feb 21 2017
Q4 2016 Merit Medical Systems Inc Earnings Release - After Market Close Feb 21 2017
MedTech Stocks Earnings Slated on Feb 21: MDT, HSIC and More Feb 20 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)